AdDiscover A Potential New T-Cell Engager Approach Targeting DLL3 for Small Cell Lung Cancer. Watch SCLC Patient Video Testimonials. Learn About Potential T-Cell Engager Technology.
AdVisit Site To See New IMFINZI Data For The POSEIDON Study. Learn About The Treatment. Healthcare Professionals: Is IMFINZI An Option For Your Patients? New Data Available.
Types: IMFINZI Approval, POSEIDON Study Data, Efficacy & Safety Data
AdWarm, Welcoming Environment. State-of-the-Art Facilities with Highly Advanced Technology. Radiation Therapy in Columbus. Treat Lung Cancer Close to Home.